Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2012
12/25/2012US8337861 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
12/25/2012US8337831 Live, oral vaccine for protection against Shigella dysenteriae serotype 1
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/25/2012US8337825 Glycosaminoglycan-antagonising MCP-1 mutants
12/20/2012WO2012174534A2 Method of treating or ameliorating metabolic disorders using clec-2
12/20/2012WO2012174430A2 Methods of making nylon intermediates from glycerol
12/20/2012WO2012174423A1 Stabilized polypeptides as regulators of rab gtpase function
12/20/2012WO2012174409A1 Stabilized variant maml peptides and uses thereof
12/20/2012WO2012174278A1 Ultra-small apob-containing particles and methods of use thereof
12/20/2012WO2012174220A1 Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
12/20/2012WO2012173477A1 Methods for chemical synthesis of biologically active compounds using supramolecular protective groups and novel compounds obtainable thereby
12/20/2012WO2012173422A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012WO2012173390A2 Method for enhancing the production yield of human papillomavirus l1 protein
12/20/2012WO2012172574A1 Vaccine composition comprising an inactivated chikungunya virus strain
12/20/2012WO2012172521A1 Soluble proteins for use as therapeutics
12/20/2012WO2012172370A1 Materials and methods for determining sensitivity potential of compounds
12/20/2012WO2012172347A1 Diagnosing and treating inflammatory bowel disease and irritable bowel syndrome
12/20/2012WO2012172346A2 Treating respiratory conditions
12/20/2012WO2012172345A2 Treating conditions associated with allergy
12/20/2012WO2012172344A2 Treating conditions associated with sepsis
12/20/2012WO2012172343A2 Treating primary sclerosing cholangitis
12/20/2012WO2012172342A2 Treating multiple sclerosis
12/20/2012WO2012172340A2 Treating mental disorders
12/20/2012WO2012172339A2 Treating inflammatory arthritis
12/20/2012WO2012172337A2 Treating cardiovascular disease
12/20/2012WO2012172336A2 Treating inflammatory skin diseases
12/20/2012WO2012172313A1 Lipid metabolism
12/20/2012WO2012172095A1 Method for generating cyan fluorescent proteins which have a reduced ph sensitivity
12/20/2012WO2012172074A1 Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
12/20/2012WO2012172058A1 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins
12/20/2012WO2012172055A1 Dimeric binding proteins based on modified ubiquitins
12/20/2012WO2012172054A1 Modified multimeric ubiquitin proteins binding vegf-a
12/20/2012WO2012172037A1 A method for the production of hydrolyzed allergens
12/20/2012WO2012171994A1 Multi substituted insulins
12/20/2012WO2012171541A1 Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins
12/20/2012WO2012171429A1 Polyethylene glycol-interferon conjugate
12/20/2012WO2012171104A1 Rabies virus like particle production in plants
12/20/2012WO2012143375A3 Hypoallergens
12/20/2012WO2012140274A3 Agonists and antagonists of the wnt pathway
12/20/2012WO2012139004A3 Insect inhibitory toxin family active against hemipteran and/or lepidopteran insects
12/20/2012WO2012131495A3 Mutant bacillus thuringiensis cry genes and methods of use
12/20/2012WO2012126123A8 Method of recovering plant-derived proteins
12/20/2012WO2012106463A3 Cardiotrophin related molecules for enhanced therapeutics
12/20/2012WO2012075333A3 Her2delta16 peptides
12/20/2012WO2012048865A3 Nitrilases with increased activity
12/20/2012WO2012046061A3 Clostridium difficile antigens
12/20/2012WO2011154420A3 Tear lipocalin muteins binding il-4 r alpha
12/20/2012WO2009013324A9 Vector particles for targeting cd34+ cells
12/20/2012US20120324605 Insectcidal protein combinations for controlling fall armyworm and european corn borer, and methods for insect resistance management
12/20/2012US20120322982 Anti-vegf antibodies
12/20/2012US20120322980 pH ADJUSTED SOY PROTEIN ISOLATE AND USES
12/20/2012US20120322974 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
12/20/2012US20120322850 Trpm-2 antisense therapy
12/20/2012US20120322744 Poly-pegylated protease inhibitors
12/20/2012US20120322739 Albumin Variants
12/20/2012US20120322738 Conjugated fviii variants
12/20/2012US20120322732 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
12/20/2012US20120322730 Methods and compositions for the prevention and treatment of anemia
12/20/2012US20120322725 Glucagon antagonist-gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
12/20/2012US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker
12/20/2012US20120322156 Membrane fusion proteins derived from reovirus
12/20/2012US20120322106 Production of Cellulases and Hemicellulases in Algal Biofuel Feedstocks
12/20/2012US20120322105 Growth factor
12/20/2012US20120322085 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
12/20/2012US20120322075 Lung Tumor Markers and Methods of Use Thereof
12/20/2012US20120322074 Prostate Tumor Markers and Methods of Use Thereof
12/20/2012US20120321687 Compositions and methods for using and identifying antimicrobial agents
12/20/2012US20120321676 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/20/2012US20120321655 Lentivirus vaccine based on the recombinant viral vaccine against yellow fever
12/20/2012US20120321654 Infectious clones of torque teno virus
12/20/2012US20120321652 Peptides for active anti-cytokine immunization
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321648 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
12/20/2012US20120321636 Antibodies specific for sclerostin and methods for increasing bone mineralization
12/20/2012US20120321585 Crosslinked Hydrogels and Related Method of Preparation
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012DE102011105372A1 Stabile, wässrige Protein-Lösung oder Protein-Dispersion, Verfahren zur Herstellung der stabilen, wässrigen Lösung oder Dispersion und Verfahren zur Herstellung von Form-oder Flächengebilden, Imprägnierungen oder Beschichtungen aus der stabilen, wässrigen Protein-Lösung oder Protein-Dispersion sowie deren Verwendung Stable, aqueous protein solution or protein dispersion, process for producing the stable aqueous solution or dispersion, and process for producing shaped or sheet-like structures, impregnation or coating from the stable aqueous protein solution or protein dispersion and the use thereof
12/20/2012DE102011104822A1 Ciliary-Neutrophic-Factor-Varianten Ciliary Neutrophic-factor variants
12/20/2012CA2839577A1 Materials and methods for determining sensitivity potential of compounds
12/20/2012CA2839427A1 Method for enhancing the production yield of human papillomavirus l1 protein
12/20/2012CA2839298A1 Anti-inflammatory pharmaceutical products
12/20/2012CA2839009A1 Rabies virus like particle production in plants
12/20/2012CA2838950A1 Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
12/20/2012CA2838888A1 A method for the production of hydrolyzed allergens
12/20/2012CA2838504A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012CA2838478A1 Soluble proteins for use as therapeutics
12/20/2012CA2838340A1 Method of treating or ameliorating metabolic disorders using clec-2
12/20/2012CA2837875A1 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins
12/20/2012CA2837804A1 Dimeric binding proteins based on modified ubiquitins
12/19/2012EP2535426A2 Mycobacterial disease detection, treatment, and drug discovery
12/19/2012EP2535419A2 Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression
12/19/2012EP2535418A1 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
12/19/2012EP2535409A1 Method for producing recombinant virus
12/19/2012EP2535355A2 Antibodies against CD38 for treatment of multiple myeloma
12/19/2012EP2535348A1 Applications of the protein muns and the derivates thereof
12/19/2012EP2535347A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
12/19/2012EP2535058A2 Stabilization of vaccines by lyophilization
12/19/2012EP2534484A1 Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 2916